Results 111 to 120 of about 46,812 (206)
Better drugs for Lyme disease: focus on the spirochete
Raphael B Stricker,1 Marianne J Middelveen2 1Union Square Medical Associates, San Francisco, CA, USA; 2Atkins Veterinary Services, Calgary, AB, Canada Abstract: Twenty-five years ago, the AIDS epidemic was wreaking havoc around the world. Although “
Stricker RB, Middelveen MJ
core
Chronic Lyme disease: misconceptions and challenges for patient management
John J HalperinDepartment of Neurosciences, Overlook Medical Center, Summit, NJ, USAAbstract: Lyme disease, infection with the tick-borne spirochete Borrelia burgdorferi, causes both specific and nonspecific symptoms.
Halperin JJ
core
The current landscape and future directions of Lyme disease vaccines. [PDF]
Chen Z +5 more
europepmc +1 more source
A poetic narrative inquiry into the lives of people with Lyme disease
Stories of people becoming critically ill with Lyme disease are finally starting to emerge within communities and social arenas. For many, there is a sigh of relief, and for others, there is a sense of confusion and concern.
Baize-Ward, Amy Michelle
core
Imported Pediatric Lyme Disease in Singapore-A Case Series. [PDF]
Tan AXN +5 more
europepmc +1 more source
Lyme Disease Presenting as Rupture Baker's Cyst: Case Report and Literature Review. [PDF]
Ghali A +5 more
europepmc +1 more source
Lyme\u27s Disease: Neurologic and Neuro-Ophthalmic Syndromes
Lyme disease is a multisystem disorder, heralded by a pathognomonic rash and characterized by prominent dermatologic, neurologic, cardiac and meumatologic manifestations.
Jacqueline Winterkorn, MD, PhD (1947-2015)
core
Predicting Lyme Disease: A One Health Approach. [PDF]
McDermott M +6 more
europepmc +1 more source
Notes from the Field: Borrelia mayonii Lyme Disease - New York, 2025. [PDF]
Nafiz TN +6 more
europepmc +1 more source
Lyme disease control 2.0: Advances and opportunities coming with Lyme disease vaccine VLA15. [PDF]
Hajdusek O +5 more
europepmc +1 more source

